Brief: Northwest Biotherapeutics says will sell to investors about 7.4 mln shares at 50 cents per share
05/07/2016 14:02
July 5 (Reuters) - Northwest Biotherapeutics Inc NWBO.O
* Entered into agreements with two new institutional
investors for direct offering with gross proceeds of $3.7
million
* Will sell to investors approximately 7.4 million shares of
common stock at a purchase price of $.50 per share
Source text for Eikon: ID:nPn3PBBXca
Further company coverage: NWBO.O
((Bengaluru Newsroom) ((+1 646 223 8780;)))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB